Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7279
Rank
HK$4.37 B
Marketcap
HK$124.92
Share price
-0.33%
Change (1 day)
-48.28%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total assets

Total assets on the balance sheet as of March 2026 : HK$1.31 Billion

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total assets are HK$1.31 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Avalon Pharma (Middle East Pharmaceutical) - Total assets on balance sheet (from 2023 to 2026)

Total assets by year

Year Total assets Change
2025-12-31HK$1.24 B14.19%
2024-12-31HK$1.09 B15.46%
2023-12-31HK$0.94 B